Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sleight

Showing results (81-90 of 290) with videos related to

Pageof 29
Sort By:
European Heart Journal|July 1, 1997
Factors associated with in-hospital death from myocardial infarctionJ Volmink, P Sleight
MMW Fortschritte Der Medizin|January 6, 2001
[The HOPE Study. What does it contribute to general practice?]J Mann, P Sleight
Drugs|May 1, 1983
Limitation of myocardial infarct size. Present statusS Yusuf, P Sleight
Journal of Hypertension|November 29, 2001
Isolated systolic hypertension: cardiovascular risk and treatment benefitsC Farsang, P Sleight
British Medical Journal|October 6, 1979
Effect of beta-blockers on arrhythmiasP Sleight, S Yusuf
Journal of Cardiovascular Risk|October 26, 1999
Smoking and ischaemic heart disease. OverviewP E Nielsen, P Sleight
The Journal of Physiology|March 1, 1972
Action potentials from ventricular mechanoreceptors stimulated by occlusion of the coronary sinus in the dogM F Muers, P Sleight
European Heart Journal|July 24, 2001
The HOPE study: comparison with other trials of secondary preventionJ E Otterstad, P Sleight
Heart (British Cardiac Society)|March 20, 1998
Enthusiasm, reality, and cost-effectiveness analysisJ M Brophy, P Sleight
Quarterly Journal of Experimental Physiology and Cognate Medical Sciences|October 1, 1972
The cardiovascular effects of coronary sinus distension in the anaesthetised dogM F Muers, P Sleight
Pageof 29

Showing results (81-90 of 290) with videos related to

Sort By:
Pageof 29
European Heart Journal|July 1, 1997
Factors associated with in-hospital death from myocardial infarctionJ Volmink, P Sleight
MMW Fortschritte Der Medizin|January 6, 2001
[The HOPE Study. What does it contribute to general practice?]J Mann, P Sleight
Drugs|May 1, 1983
Limitation of myocardial infarct size. Present statusS Yusuf, P Sleight
Journal of Hypertension|November 29, 2001
Isolated systolic hypertension: cardiovascular risk and treatment benefitsC Farsang, P Sleight
British Medical Journal|October 6, 1979
Effect of beta-blockers on arrhythmiasP Sleight, S Yusuf
Journal of Cardiovascular Risk|October 26, 1999
Smoking and ischaemic heart disease. OverviewP E Nielsen, P Sleight
The Journal of Physiology|March 1, 1972
Action potentials from ventricular mechanoreceptors stimulated by occlusion of the coronary sinus in the dogM F Muers, P Sleight
European Heart Journal|July 24, 2001
The HOPE study: comparison with other trials of secondary preventionJ E Otterstad, P Sleight
Heart (British Cardiac Society)|March 20, 1998
Enthusiasm, reality, and cost-effectiveness analysisJ M Brophy, P Sleight
Quarterly Journal of Experimental Physiology and Cognate Medical Sciences|October 1, 1972
The cardiovascular effects of coronary sinus distension in the anaesthetised dogM F Muers, P Sleight
Pageof 29